Costimulation and endogenous MHC ligands contribute to T cell recognition
暂无分享,去创建一个
[1] K. Garcia,et al. Alanine Scanning Mutagenesis of an αβ T Cell Receptor: Mapping the Energy of Antigen Recognition , 1998 .
[2] D. Yelon,et al. Alterations in CD4-binding regions of the MHC class II molecule I-Ek do not impede CD4+ T cell development. , 1999, Journal of immunology.
[3] W. Paul,et al. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice , 1992, The Journal of experimental medicine.
[4] S. Singer. Intercellular communication and cell-cell adhesion. , 1992, Science.
[5] L. Glimcher,et al. Sequences and factors: a guide to MHC class-II transcription. , 1992, Annual review of immunology.
[6] Y. Chien,et al. A Murine T Cell Receptor Gene Complex: Isolation, Structure and Rearrangement , 1984, Immunological reviews.
[7] J. Guardiola,et al. Identification of a CD4 binding site on the β2 domain of HLA-DR molecules , 1992, Nature.
[8] M. Bevan,et al. Selecting and maintaining a diverse T-cell repertoire , 1999, Nature.
[9] K. Garcia,et al. Alanine scanning mutagenesis of an alphabeta T cell receptor: mapping the energy of antigen recognition. , 1998, Immunity.
[10] M. Davis,et al. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. , 1998, Science.
[11] E. Unanue,et al. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. , 1997, Immunity.
[12] Michael Loran Dustin,et al. Costimulation: Building an Immunological Synapse , 1999, Science.
[13] F. Lemonnier,et al. Differential requirements for survival and proliferation of CD8 naïve or memory T cells. , 1997, Science.
[14] Ursula Esser,et al. Mapping T-cell receptor–peptide contacts by variant peptide immunization of single-chain transgenics , 1992, Nature.
[15] J. Bluestone,et al. The Complexities of T‐Cell Co‐stimulation: CD28 and Beyond , 1996, Immunological reviews.
[16] B. Motyka,et al. Naturally occurring low affinity peptide/MHC class I ligands can mediate negative selection and T cell activation. , 1998, Journal of immunology.
[17] G. Nolan,et al. Simultaneous fluorescence-activated cell sorter analysis of two distinct transcriptional elements within a single cell using engineered green fluorescent proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Neefjes,et al. Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface , 1996, The Journal of cell biology.
[19] F. Alt,et al. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction , 1998, Current Biology.
[20] T. Brocker. Survival of Mature CD4 T Lymphocytes Is Dependent on Major Histocompatibility Complex Class II–expressing Dendritic Cells , 1997, The Journal of experimental medicine.
[21] P. Allen,et al. A Kinetic Threshold between Negative and Positive Selection Based on the Longevity of the T Cell Receptor–Ligand Complex , 1999, The Journal of experimental medicine.
[22] W. Reith,et al. Regulation of MHC class II genes: lessons from a disease. , 1996, Annual review of immunology.
[23] Michael Loran Dustin,et al. Influence of receptor lateral mobility on adhesion strengthening between membranes containing LFA-3 and CD2 , 1991, The Journal of cell biology.
[24] Mark M. Davis,et al. A T Cell Receptor–specific Blockade of Positive Selection , 1999, The Journal of experimental medicine.
[25] A. Weiss,et al. Nuclear factor of activated T cells and AP-1 are insufficient for IL-2 promoter activation: requirement for CD28 up-regulation of RE/AP. , 1998, Journal of immunology.
[26] C. Thompson,et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. , 1995, Immunity.
[27] A. Lanzavecchia,et al. Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton , 1995, The Journal of experimental medicine.
[28] M. Davis,et al. Differential clustering of CD4 and CD3zeta during T cell recognition. , 2000, Science.
[29] P J Blair,et al. CD28 co-receptor signal transduction in T-cell activation. , 1997, Biochemical Society transactions.
[30] S. Singer,et al. Cell biology of cytotoxic and helper T cell functions: immunofluorescence microscopic studies of single cells and cell couples. , 1989, Annual review of immunology.
[31] J. Allison,et al. Co-stimulation in T cell responses. , 1997, Current opinion in immunology.
[32] P. Jung,et al. Too quiet to hear a whisper , 1997, Nature.
[33] N. Hogg,et al. Regulation of leukocyte integrin function: Affinity vs. avidity , 1996, Journal of cellular biochemistry.
[34] A. Lanzavecchia,et al. T lymphocyte costimulation mediated by reorganization of membrane microdomains. , 1999, Science.
[35] M. Davis,et al. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). , 1994, Journal of immunology.
[36] Colin R. F. Monks,et al. Three-dimensional segregation of supramolecular activation clusters in T cells , 1998, Nature.
[37] G. Crabtree,et al. The vav exchange factor is an essential regulator in actin-dependent receptor translocation to the lymphocyte-antigen-presenting cell interface. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[38] R. Germain,et al. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8 , 1992, Nature.
[39] C. Figdor,et al. Signalling and adhesive properties of the integrin leucocyte function-associated antigen 1 (LFA-1). , 1997, Biochemical Society transactions.
[40] H. Arakawa,et al. MHC class II molecules are not required for survival of newly generated CD4+ T cells, but affect their long-term life span. , 1996, Immunity.
[41] J. Riberdy,et al. Disruption of the CD4-major histocompatibility complex class II interaction blocks the development of CD4(+) T cells in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[42] H. Grey,et al. The minimal number of antigen‐major histocompatibility complex class II complexes required for activation of naive and primed T cells , 1997, European journal of immunology.
[43] Michael Loran Dustin,et al. Influence of receptor lateral mobility on adhesion strengthening between membranes containing LFA-3 and CD2 , 1991, The Journal of cell biology.
[44] C. Benoist,et al. Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses. , 1997, Immunity.
[45] X. Shen,et al. Selection and function of CD4+ T lymphocytes in transgenic mice expressing mutant MHC class II molecules deficient in their interaction with CD4. , 1998, Journal of immunology.
[46] R. Glas,et al. Recognition of the Major Histocompatibility Complex Restriction Element Modulates CD8+ T Cell Specificity and Compensates for Loss of T Cell Receptor Contacts with the Specific Peptide , 1999, The Journal of experimental medicine.
[47] S. Davis,et al. The structure and ligand interactions of CD2: implications for T-cell function. , 1996, Immunology today.
[48] Mark M. Davis,et al. Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand , 1989, Cell.
[49] Christoph Wülfing,et al. Kinetics and Extent of T Cell Activation as Measured with the Calcium Signal , 1997, The Journal of experimental medicine.
[50] Michael L. Dustin,et al. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1 , 1989, Nature.
[51] S. Bromley,et al. The immunological synapse: a molecular machine controlling T cell activation. , 1999, Science.
[52] M. Davis,et al. Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH , 1991, The Journal of experimental medicine.
[53] J. Sprent,et al. Induction of MHC-restricted specificity and tolerance in the thymus , 1986, Immunologic research.